内视镜逆行性造影(ERCP) 市场规模、份额和成长分析：按类型、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

内视镜逆行性造影（ERCP）市场规模2022年估值为19亿美元，在预测期内从2023年的20.9亿美元增长到2031年的44.1亿美元（预计复合年增长率为9.80%） （2024） -2031）。

微创手术技术的兴起增加了对内视镜逆行性造影（ERCP）手术的需求，为未来几年产业的强劲成长奠定了基础。选择 ERCP 的患者数量不断增加，主要是因为微创方法的优点，与传统手术技术相比，这种方法可以实现更快的恢復时间和更少的併发症。此外，美国癌症协会 2023 年 1 月年度报告预测，美国新增约 41,210 例肝癌病例，凸显了对先进诊断和治疗解决方案的迫切需求。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 成功的关键因素
• 市场吸引力指数
• 竞争程度
• 主要投资机会
• 生态系绘图

内视镜逆行性造影(ERCP) 市场：依类型

• 市场概况
• 内视镜
• 内视镜治疗装置
• 影像系统
• 能源装置
• 其他的

内视镜逆行性造影(ERCP) 市场：依应用分类

• 市场概况
• 胆管括约肌切开术
• 胆管支架
• 胆管扩张
• 胰管支架置入术
• 胰管扩张
• 胰臟括约肌切开术

内视镜逆行性造影(ERCP) 市场：依最终用户分类

• 市场概况
• 医院/诊所
• 门诊手术中心

内视镜逆行性造影(ERCP) 市场：依地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Olympus Corporation
• CONMED Corporation
• HOYA Corporation
• Fujifilm Holdings Corporation
• KARL STORZ SE & Co. KG
• Ambu A/S
• Johnson & Johnson
• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• B. Braun Melsungen AG.

Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.09 billion in 2023 to USD 4.41 billion by 2031, growing at a CAGR of 9.80% in the forecast period (2024-2031).

The rise of minimally invasive surgical methods has led to an increased demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, setting the stage for a robust industry growth in the coming years. The growing number of patients opting for ERCP is primarily driven by the benefits of minimally invasive approaches, which promise quicker recovery times and fewer complications compared to traditional surgical techniques. Additionally, the American Cancer Society's January 2023 annual report projects approximately 41,210 new cases of liver cancer in the United States, underscoring the urgent requirement for advanced diagnostic and therapeutic solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Endoscopic Retrograde Cholangiopancreatography Market Segmental Analysis

Endoscopic retrograde cholangiopancreatography market is segmented based on product type, application, end user, and region. Based on product type, the market is segmented into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Based on application, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Pancreatic Duct Dilatation, Pancreatic Sphincterotomy. Based on end user, the market is segmented into hospitals & clinics and ambulatory surgical centers, and others. Based on region, the market is segmented into North America, Europe, APAC, Middle East and Africa, LATAM.

Drivers of the Endoscopic Retrograde Cholangiopancreatography Market

ERCP, short for endoscopic retrograde cholangiopancreatography, is a specialized medical procedure designed for both diagnosing and treating conditions affecting the pancreas, liver, gallbladder, and bile ducts. This diagnostic and therapeutic technique combines luminal endoscopy with fluoroscopy-based imaging, providing a comprehensive approach to addressing pancreatobiliary diseases. The procedure involves using an endoscope-a flexible, elongated, and illuminated tube-alongside X-ray technology. The endoscope is carefully guided through the digestive system to enable direct visualization of the targeted organs and systems. Concurrently, X-ray images are captured to provide detailed information about the pancreas, liver, gallbladder, and bile ducts.

Restraints in the Endoscopic Retrograde Cholangiopancreatography Market

The market's growth is constrained by strict regulatory guidelines imposed by regulatory bodies in various countries, which present challenges for introducing new technologies. Compliance with these regulations requires rigorous testing and adherence to safety and efficacy standards, contributing to a complex and time-consuming approval process for new medical technologies. Despite these regulatory challenges, the market is experiencing some positive impacts. The increase in disposable income, particularly in developing countries, has emerged as a catalyst for market expansion.

Market Trends of the Endoscopic Retrograde Cholangiopancreatography Market

The market is expected to gain substantial momentum from strategic initiatives undertaken by key industry players, such as impactful actions including product launches, mergers, and acquisitions. A notable example is the strategic distribution agreement forged between Olympus and EndoClot Plus in April 2022. EndoClot Plus, a specialist in hemostasis technology, introduced the EndoClot PHS-a nonthermal, nontraumatic method designed for fast and reliable hemostasis in gastrointestinal bleeding. This collaboration highlights the market's commitment to advancing existing solutions in therapeutic endoscopy.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Endoscopic Retrograde Cholangiopancreatography Market by Type

• Market Overview
• Endoscopes
• Endo-therapy Devices
• Imaging Systems
• Energy Devices
• Others

Endoscopic Retrograde Cholangiopancreatography Market by Application

• Market Overview
• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Duct Stenting
• Pancreatic Duct Dilatation
• Pancreatic Sphincterotomy

Endoscopic Retrograde Cholangiopancreatography Market by End User

• Market Overview
• Hospitals & Clinic
• Ambulatory Surgical Centres

Endoscopic Retrograde Cholangiopancreatography Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOYA Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambu A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments